Ortivus AB (publ) (ORTI-B.ST)
SEK 1.48
(-6.62%)
SEK 1.48
(-6.62%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 48.45 Million SEK | 9.79% |
| 2022 | 42.06 Million SEK | 19.17% |
| 2021 | 35.29 Million SEK | 10.2% |
| 2020 | 32.03 Million SEK | -11.13% |
| 2019 | 36.04 Million SEK | 3.22% |
| 2018 | 34.92 Million SEK | -13.42% |
| 2017 | 40.33 Million SEK | -25.08% |
| 2016 | 53.83 Million SEK | -13.97% |
| 2015 | 62.57 Million SEK | 44.98% |
| 2014 | 43.16 Million SEK | 27.98% |
| 2013 | 33.72 Million SEK | 8.11% |
| 2012 | 31.19 Million SEK | -47.49% |
| 2011 | 59.4 Million SEK | 2.17% |
| 2010 | 58.14 Million SEK | -39.34% |
| 2009 | 95.85 Million SEK | -6.41% |
| 2008 | 102.42 Million SEK | -39.43% |
| 2007 | 169.09 Million SEK | -31.66% |
| 2006 | 247.44 Million SEK | 77.57% |
| 2005 | 139.35 Million SEK | 29.36% |
| 2004 | 107.72 Million SEK | -11.61% |
| 2003 | 121.87 Million SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 10.99 Million SEK | 49.65% |
| 2024 Q2 | 12.63 Million SEK | 19.24% |
| 2023 Q3 | 15.88 Million SEK | 28.72% |
| 2023 Q1 | 12.98 Million SEK | 2.02% |
| 2023 FY | 46.18 Million SEK | 9.79% |
| 2023 Q4 | 7.34 Million SEK | -53.75% |
| 2023 Q2 | 12.34 Million SEK | -4.94% |
| 2022 Q1 | 9.63 Million SEK | -7.51% |
| 2022 Q2 | 11.64 Million SEK | 20.81% |
| 2022 Q3 | 8.86 Million SEK | -23.87% |
| 2022 Q4 | 12.72 Million SEK | 43.58% |
| 2022 FY | 42.06 Million SEK | 19.17% |
| 2021 Q3 | 9.67 Million SEK | 15.46% |
| 2021 Q2 | 8.37 Million SEK | -16.71% |
| 2021 FY | 35.29 Million SEK | 10.2% |
| 2021 Q1 | 10.05 Million SEK | -22.77% |
| 2021 Q4 | 10.42 Million SEK | 7.77% |
| 2020 Q3 | 6.6 Million SEK | 44.41% |
| 2020 Q1 | 7.83 Million SEK | -7.03% |
| 2020 Q2 | 4.57 Million SEK | -41.68% |
| 2020 FY | 32.03 Million SEK | -11.13% |
| 2020 Q4 | 13.02 Million SEK | 97.26% |
| 2019 Q4 | 8.43 Million SEK | 10.57% |
| 2019 FY | 36.04 Million SEK | 3.22% |
| 2019 Q3 | 7.62 Million SEK | -21.33% |
| 2019 Q2 | 9.69 Million SEK | -5.88% |
| 2019 Q1 | 10.29 Million SEK | 20.7% |
| 2018 FY | 34.92 Million SEK | -13.42% |
| 2018 Q1 | 9.12 Million SEK | -18.55% |
| 2018 Q2 | 9.42 Million SEK | 3.34% |
| 2018 Q3 | 7.84 Million SEK | -16.8% |
| 2018 Q4 | 8.53 Million SEK | 8.79% |
| 2017 Q4 | 11.19 Million SEK | 30.18% |
| 2017 Q3 | 8.6 Million SEK | -22.76% |
| 2017 Q2 | 11.13 Million SEK | 18.54% |
| 2017 Q1 | 9.39 Million SEK | -33.32% |
| 2017 FY | 40.33 Million SEK | -25.08% |
| 2016 Q1 | 14.4 Million SEK | -33.89% |
| 2016 FY | 53.83 Million SEK | -13.97% |
| 2016 Q4 | 14.08 Million SEK | 13.94% |
| 2016 Q3 | 12.36 Million SEK | -4.69% |
| 2016 Q2 | 12.97 Million SEK | -9.97% |
| 2015 Q2 | 14.32 Million SEK | 7.08% |
| 2015 Q3 | 13.08 Million SEK | -8.64% |
| 2015 Q1 | 13.37 Million SEK | -3.83% |
| 2015 Q4 | 21.79 Million SEK | 66.56% |
| 2015 FY | 62.57 Million SEK | 44.98% |
| 2014 Q1 | 8.31 Million SEK | -25.7% |
| 2014 FY | 43.16 Million SEK | 27.98% |
| 2014 Q3 | 10.25 Million SEK | -4.08% |
| 2014 Q4 | 13.9 Million SEK | 35.69% |
| 2014 Q2 | 10.68 Million SEK | 28.45% |
| 2013 Q3 | 6.92 Million SEK | -17.97% |
| 2013 Q4 | 11.19 Million SEK | 61.61% |
| 2013 FY | 33.72 Million SEK | 8.11% |
| 2013 Q1 | 7.15 Million SEK | -2.57% |
| 2013 Q2 | 8.44 Million SEK | 18.03% |
| 2012 Q2 | 7.86 Million SEK | -0.84% |
| 2012 FY | 31.19 Million SEK | -47.49% |
| 2012 Q1 | 7.93 Million SEK | -58.28% |
| 2012 Q3 | 8.05 Million SEK | 2.43% |
| 2012 Q4 | 7.34 Million SEK | -8.81% |
| 2011 Q2 | 16.53 Million SEK | 41.7% |
| 2011 Q3 | 12.19 Million SEK | -26.22% |
| 2011 Q4 | 19.01 Million SEK | 55.85% |
| 2011 FY | 59.4 Million SEK | 2.17% |
| 2011 Q1 | 11.66 Million SEK | -10.47% |
| 2010 Q2 | 18.35 Million SEK | 34.59% |
| 2010 Q3 | 13.12 Million SEK | -28.51% |
| 2010 FY | 58.14 Million SEK | -39.34% |
| 2010 Q4 | 13.03 Million SEK | -0.69% |
| 2010 Q1 | 13.63 Million SEK | 0.0% |
| 2009 FY | 95.85 Million SEK | -6.41% |
| 2008 FY | 102.42 Million SEK | -39.43% |
| 2007 FY | 169.09 Million SEK | -31.66% |
| 2006 FY | 247.44 Million SEK | 77.57% |
| 2005 FY | 139.35 Million SEK | 29.36% |
| 2004 FY | 107.72 Million SEK | -11.61% |
| 2003 FY | 121.87 Million SEK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AddLife AB (publ) | 3.01 Billion SEK | 98.392% |
| Biotage AB (publ) | 637 Million SEK | 92.394% |
| Bonesupport Holding AB (publ) | 510.93 Million SEK | 90.517% |
| Doxa AB (publ) | -259.5 Million SEK | 118.672% |
| Elekta AB (publ) | 3.39 Billion SEK | 98.571% |
| iZafe Group AB (publ) | 35.92 Million SEK | -34.861% |
| Ortivus AB (publ) | 48.45 Million SEK | 0.0% |
| Q-linea AB (publ) | -43 Thousand SEK | 112781.395% |
| S2Medical AB (publ) | 20.3 Million SEK | -138.675% |
| Synsam AB (publ) | 3.76 Billion SEK | 98.712% |